(2-Chloro-4-morpholinopyrido[3,2-d]pyrimidin-6-yl)methanol → (2-(5-fluoro-1H-indol-4-yl)-4-morpholinopyrido[3,2-d]pyrimidin-6-yl)methanol
反応式
Cl[C:2]1[N:3]=[C:4]([N:14]2[CH2:19][CH2:18][O:17][CH2:16][CH2:15]2)[C:5]2[N:11]=[C:10]([CH2:12][OH:13])[CH:9]=[CH:8][C:6]=2[N:7]=1.[Si]([N:27]1[C:35]2[C:30](=[C:31](B3OC(C)(C)C(C)(C)O3)[C:32]([F:36])=[CH:33][CH:34]=2)[CH:29]=[CH:28]1)(C(C)(C)C)(C)C>>[F:36][C:32]1[C:31]([C:2]2[N:3]=[C:4]([N:14]3[CH2:19][CH2:18][O:17][CH2:16][CH2:15]3)[C:5]3[N:11]=[C:10]([CH2:12][OH:13])[CH:9]=[CH:8][C:6]=3[N:7]=2)=[C:30]2[C:35](=[CH:34][CH:33]=1)[NH:27][CH:28]=[CH:29]2参加物
3
実験手順
(2-Chloro-4-morpholinopyrido[3,2-d]pyrimidin-6-yl)methanol 6 (0.1 g) was reacted with 1-(tert-butyldimethylsilyl)-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole via General Procedure A to produce 73.4 mg of 108 following reverse phase HPLC purification. MS (Q1) 380.1 (M)+
後処理
- customto produce
- custom73.4 mg of 108 following reverse phase HPLC purification
出典と根拠
- ORDレコード
- ord-9c15e37b3b9c4ad6b656dea5b64969b3
- 出典データセット
- uspto-grants-2013_10
- 特許番号
- US08563540B2
反応ノート
読み込み中…